In The Press

Vivodyne raises $40M for human tissue drug testing

Katherine Davis
•
May 29, 2025
VC, PE, M&A Biotech Reporter
Share on

Discover More Articles

view all posts
As the FDA and NIH eschew animal testing, startup raises $40 million
Vivodyne to Replace Animal Testing With $40 Million Funding
Advantages and Impact of FDA’s Plan to Phase Out Animal Testing for mAbs and Other Drugs
FDA Wants a Shift Away from Animal Testing
FDA Unveils Plan to Replace Animal Testing with Organoids
Human data before the clinic.
Connect With Us
Applications
San Francisco, USA
© 2024 Vivodyne
Privacy
linkedinlinkedinxx